Article
Contemporary Management of Acute Myeloid Leukemia: A Review.
JAMA oncology - 1 Oct 2024
Venugopal Sangeetha, Sekeres Mikkael A
Abstract excerpt
Importance: Acute myeloid leukemia (AML) is a clonal hematopoietic cancer that disrupts normal hematopoiesis, ultimately leading to bone marrow failure and death. The annual incidence rate of AML is 4.1 per 100 000 people in the US and is higher in patients older than 65 years. Acute myeloid leuk...
Topics
- Humans
- Leukemia, Myeloid, Acute
- Nucleophosmin
- Molecular Targeted Therapy
- Mutation
- Prognosis
- Bridged Bicyclo Compounds, Heterocyclic
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
